These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2410102)

  • 1. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beagles.
    Levin VA; Byrd D; Sikic BI; Etiz BB; Campbell J; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3810-5. PubMed ID: 2410102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
    Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
    Neuwelt EA; Glasberg M; Frenkel E; Barnett P
    Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-beta-D-arabinofuranosylcytosine in nonhuman primates.
    Lopez JA; Beardsley GP; Krikorian JG; Mortara RW; Agarwal RP
    Cancer Res; 1983 Nov; 43(11):5190-3. PubMed ID: 6616454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution in cerebrospinal fluid, blood, and lymph of epidurally injected morphine and inulin in dogs.
    Durant PA; Yaksh TL
    Anesth Analg; 1986 Jun; 65(6):583-92. PubMed ID: 3706799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary toxicity studies of bleomycin and talisomycin.
    Schlein A; Schurig JE; Baca C; Bradner WT; Crooks ST
    Cancer Treat Rep; 1981; 65(3-4):291-7. PubMed ID: 6165468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 4-aminopyridine derivatives in dogs.
    Olby NJ; Smith DT; Humphrey J; Spinapolice K; Parke N; Mehta PM; Dise D; Papich M
    J Vet Pharmacol Ther; 2009 Oct; 32(5):485-91. PubMed ID: 19754916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
    Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
    Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies on the entry of d-amphetamine into the central nervous system: I. Cerebrospinal fluid.
    Simpson LL; Barkai A
    J Pharmacol Exp Ther; 1980 Mar; 212(3):541-5. PubMed ID: 7359354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
    Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
    Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa.
    Heideman RL; Cole DE; Balis F; Sato J; Reaman GH; Packer RJ; Singher LJ; Ettinger LJ; Gillespie A; Sam J
    Cancer Res; 1989 Feb; 49(3):736-41. PubMed ID: 2491958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.